Trials / Completed
CompletedNCT01606670
Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease
A Multicenter, Non-interventional Study With Neupro® to Evaluate the Perception of Pain Associated With Idiopathic Parkinson's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 93 (actual)
- Sponsor
- UCB Pharma GmbH · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the perception of pain associated with Parkinson´s Disease in patients who receive Neupro® for the first time.
Conditions
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2012-05-28
- Last updated
- 2018-04-04
- Results posted
- 2015-04-29
Locations
27 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT01606670. Inclusion in this directory is not an endorsement.